Concepts (139)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ferrosoferric Oxide | 12 | 2023 | 25 | 3.130 |
Why?
|
| Magnetic Resonance Imaging | 25 | 2023 | 3570 | 2.240 |
Why?
|
| Positron-Emission Tomography | 13 | 2023 | 305 | 2.050 |
Why?
|
| Contrast Media | 8 | 2022 | 479 | 1.320 |
Why?
|
| Fluorodeoxyglucose F18 | 10 | 2023 | 147 | 1.270 |
Why?
|
| Cartilage, Articular | 3 | 2022 | 57 | 1.060 |
Why?
|
| Cartilage Diseases | 3 | 2023 | 13 | 1.050 |
Why?
|
| Whole Body Imaging | 6 | 2023 | 29 | 1.000 |
Why?
|
| Magnetite Nanoparticles | 3 | 2020 | 9 | 0.890 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 2 | 2023 | 85 | 0.880 |
Why?
|
| Neoplasms | 9 | 2023 | 2786 | 0.720 |
Why?
|
| Radiopharmaceuticals | 8 | 2023 | 167 | 0.710 |
Why?
|
| Cell Tracking | 2 | 2023 | 15 | 0.670 |
Why?
|
| Multimodal Imaging | 6 | 2020 | 115 | 0.650 |
Why?
|
| Femur Head Necrosis | 1 | 2018 | 4 | 0.620 |
Why?
|
| Osteosarcoma | 1 | 2021 | 254 | 0.610 |
Why?
|
| Bone Marrow Neoplasms | 3 | 2023 | 23 | 0.600 |
Why?
|
| Edema | 2 | 2022 | 136 | 0.560 |
Why?
|
| Osteonecrosis | 1 | 2017 | 11 | 0.560 |
Why?
|
| Fractures, Spontaneous | 1 | 2017 | 18 | 0.560 |
Why?
|
| Stem Cell Transplantation | 1 | 2019 | 238 | 0.550 |
Why?
|
| Bone Diseases | 1 | 2017 | 44 | 0.550 |
Why?
|
| Bone Marrow Diseases | 1 | 2017 | 41 | 0.550 |
Why?
|
| Swine | 7 | 2023 | 1207 | 0.550 |
Why?
|
| Bone Neoplasms | 4 | 2023 | 423 | 0.540 |
Why?
|
| Bone Marrow | 2 | 2022 | 324 | 0.540 |
Why?
|
| Bone Marrow Transplantation | 1 | 2018 | 575 | 0.500 |
Why?
|
| Glucocorticoids | 1 | 2017 | 382 | 0.460 |
Why?
|
| Swine, Miniature | 4 | 2022 | 50 | 0.460 |
Why?
|
| Brain Diseases | 1 | 2017 | 298 | 0.450 |
Why?
|
| Leukemia | 1 | 2017 | 370 | 0.440 |
Why?
|
| Young Adult | 13 | 2023 | 9042 | 0.430 |
Why?
|
| Heart Diseases | 1 | 2017 | 493 | 0.400 |
Why?
|
| Nanoparticles | 3 | 2023 | 232 | 0.370 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 5 | 2023 | 142 | 0.340 |
Why?
|
| Adolescent | 14 | 2023 | 19328 | 0.330 |
Why?
|
| Positron Emission Tomography Computed Tomography | 2 | 2021 | 80 | 0.320 |
Why?
|
| Gadolinium | 2 | 2021 | 107 | 0.310 |
Why?
|
| Artificial Intelligence | 2 | 2023 | 241 | 0.300 |
Why?
|
| Brain | 1 | 2020 | 2999 | 0.300 |
Why?
|
| Sarcoma | 3 | 2019 | 181 | 0.300 |
Why?
|
| Stem Cells | 3 | 2023 | 706 | 0.290 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 1695 | 0.290 |
Why?
|
| Child | 18 | 2023 | 24356 | 0.280 |
Why?
|
| Sensitivity and Specificity | 3 | 2022 | 2054 | 0.250 |
Why?
|
| Prospective Studies | 5 | 2023 | 6153 | 0.230 |
Why?
|
| Treatment Outcome | 5 | 2020 | 12382 | 0.220 |
Why?
|
| Adult | 11 | 2023 | 29624 | 0.210 |
Why?
|
| Tissue Distribution | 2 | 2021 | 392 | 0.210 |
Why?
|
| Gallium Radioisotopes | 1 | 2022 | 7 | 0.200 |
Why?
|
| Adipose Tissue | 2 | 2022 | 466 | 0.190 |
Why?
|
| Vascular System Injuries | 1 | 2022 | 54 | 0.190 |
Why?
|
| Pleura | 1 | 2021 | 25 | 0.190 |
Why?
|
| Staining and Labeling | 2 | 2020 | 187 | 0.180 |
Why?
|
| Chondrogenesis | 1 | 2021 | 26 | 0.180 |
Why?
|
| Ascorbic Acid | 1 | 2021 | 78 | 0.180 |
Why?
|
| Animals | 9 | 2023 | 34206 | 0.180 |
Why?
|
| Humans | 24 | 2023 | 125035 | 0.170 |
Why?
|
| Radiation Exposure | 1 | 2021 | 42 | 0.170 |
Why?
|
| Pediatrics | 2 | 2020 | 1149 | 0.170 |
Why?
|
| Brain Chemistry | 1 | 2020 | 125 | 0.170 |
Why?
|
| Histiocytosis, Langerhans-Cell | 1 | 2023 | 221 | 0.170 |
Why?
|
| Gadolinium DTPA | 1 | 2019 | 47 | 0.170 |
Why?
|
| Administration, Intravenous | 1 | 2020 | 143 | 0.160 |
Why?
|
| Cell Differentiation | 3 | 2023 | 1895 | 0.160 |
Why?
|
| Male | 12 | 2023 | 61436 | 0.160 |
Why?
|
| Kidney Transplantation | 2 | 2018 | 642 | 0.160 |
Why?
|
| Glioblastoma | 1 | 2022 | 330 | 0.160 |
Why?
|
| Proof of Concept Study | 1 | 2018 | 29 | 0.150 |
Why?
|
| Bone Regeneration | 1 | 2018 | 21 | 0.150 |
Why?
|
| Iron | 1 | 2021 | 270 | 0.150 |
Why?
|
| Lymph Nodes | 1 | 2020 | 379 | 0.140 |
Why?
|
| Systems Integration | 1 | 2017 | 27 | 0.140 |
Why?
|
| Radiology | 1 | 2019 | 106 | 0.140 |
Why?
|
| Femur | 1 | 2017 | 66 | 0.140 |
Why?
|
| Allografts | 1 | 2018 | 191 | 0.140 |
Why?
|
| Female | 10 | 2022 | 66718 | 0.140 |
Why?
|
| Pilot Projects | 1 | 2021 | 1397 | 0.140 |
Why?
|
| Radiography | 1 | 2019 | 820 | 0.130 |
Why?
|
| Observer Variation | 1 | 2017 | 298 | 0.130 |
Why?
|
| Lymphoma | 1 | 2018 | 321 | 0.120 |
Why?
|
| Macrophages | 1 | 2018 | 620 | 0.110 |
Why?
|
| Graft Rejection | 1 | 2018 | 589 | 0.110 |
Why?
|
| Cancer Survivors | 1 | 2017 | 211 | 0.110 |
Why?
|
| Retrospective Studies | 3 | 2021 | 16312 | 0.100 |
Why?
|
| Case-Control Studies | 1 | 2020 | 3299 | 0.100 |
Why?
|
| Organ Preservation | 2 | 2011 | 45 | 0.100 |
Why?
|
| Neoplasm Staging | 3 | 2023 | 1274 | 0.100 |
Why?
|
| Disease Progression | 1 | 2017 | 2061 | 0.090 |
Why?
|
| Receptors, Complement | 1 | 2011 | 32 | 0.090 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 2889 | 0.090 |
Why?
|
| Brain Death | 1 | 2011 | 61 | 0.090 |
Why?
|
| Catheterization | 1 | 2011 | 236 | 0.080 |
Why?
|
| Cryopreservation | 1 | 2010 | 74 | 0.080 |
Why?
|
| Child, Preschool | 3 | 2023 | 13984 | 0.080 |
Why?
|
| Pulsatile Flow | 1 | 2010 | 128 | 0.080 |
Why?
|
| Perfusion | 1 | 2010 | 207 | 0.080 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 4390 | 0.080 |
Why?
|
| Prognosis | 1 | 2017 | 4630 | 0.070 |
Why?
|
| Kidney | 1 | 2011 | 1366 | 0.060 |
Why?
|
| Cartilage | 1 | 2023 | 48 | 0.050 |
Why?
|
| Risk Factors | 1 | 2017 | 10282 | 0.050 |
Why?
|
| Epiphyses | 1 | 2022 | 6 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2022 | 2100 | 0.050 |
Why?
|
| Knee Joint | 1 | 2022 | 158 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2020 | 3051 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2023 | 584 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2021 | 292 | 0.040 |
Why?
|
| Chelating Agents | 1 | 2019 | 42 | 0.040 |
Why?
|
| Drug Interactions | 1 | 2020 | 256 | 0.040 |
Why?
|
| Hematinics | 1 | 2019 | 55 | 0.040 |
Why?
|
| Germany | 1 | 2019 | 65 | 0.040 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2018 | 37 | 0.040 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2017 | 33 | 0.040 |
Why?
|
| Forecasting | 1 | 2019 | 352 | 0.040 |
Why?
|
| Antigens, CD | 1 | 2018 | 432 | 0.030 |
Why?
|
| Kinetics | 1 | 2018 | 1332 | 0.030 |
Why?
|
| Receptors, Cell Surface | 1 | 2018 | 470 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2022 | 3345 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2020 | 1096 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2022 | 1718 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 3424 | 0.030 |
Why?
|
| Rats, Inbred Strains | 1 | 2011 | 233 | 0.020 |
Why?
|
| Complement Activation | 1 | 2011 | 52 | 0.020 |
Why?
|
| Biomarkers | 1 | 2020 | 3081 | 0.020 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2011 | 40 | 0.020 |
Why?
|
| Procaine | 1 | 2010 | 7 | 0.020 |
Why?
|
| Organ Preservation Solutions | 1 | 2010 | 16 | 0.020 |
Why?
|
| Potassium Chloride | 1 | 2010 | 54 | 0.020 |
Why?
|
| Mannitol | 1 | 2010 | 48 | 0.020 |
Why?
|
| Cold Temperature | 1 | 2010 | 78 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2011 | 243 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2011 | 445 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2018 | 1661 | 0.020 |
Why?
|
| Infant | 1 | 2022 | 12462 | 0.020 |
Why?
|
| Mice | 1 | 2022 | 17621 | 0.020 |
Why?
|
| Cytokines | 1 | 2011 | 1285 | 0.020 |
Why?
|
| Glucose | 1 | 2010 | 877 | 0.010 |
Why?
|
| Rats | 1 | 2011 | 3717 | 0.010 |
Why?
|